Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Selenium for Prevention of Mucositis in AML/ALL Patients Undergoing HSCT
NCT01432873Phase 2Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2011
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of selenium in mucositis, sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
selenium
03
Conditions
mucositis
Beyond the preview
Go deeper on NCT01432873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432873.